May 14, 2025

Semaglutide at Half Dose—Same Effect?

“When care is designed around the patient, lower doses often prove sufficient."

Reuters

May 14, 2025

Home Wash Leaves Scrubs Full of Superbugs

Home washing machines often fail to disinfect health care workers' uniforms, leaving antibiotic-resistant bacteria behind.

Conexiant

May 14, 2025

New Guidelines Trim Fat and Pages

Health Secretary Robert F. Kennedy, Jr. discusses upcoming 4-page dietary guidelines directing Americans to 'eat whole food' with major reforms, promising an early release before August.

Reuters

May 14, 2025

Mind the Gap: Could GLP-1 RAs Bridge Body and Brain Treatment?

A systematic review reveals that GLP-1 receptor agonists not only address psychotropic-induced metabolic disorders but also may positively impact mental wellbeing.

Conexiant

May 13, 2025

GLP-1s May Protect Against Obesity-Related Cancer

First-generation GLP-1 receptor agonists provide comparable protection against obesity-related cancers as bariatric surgery.

Conexiant

May 05, 2025

True Heart Age Beyond Birthdays

New research uses cardiac MRI to calculate "functional heart age," showing obesity and other risk factors can age the heart by decades.

Conexiant

May 01, 2025

Semaglutide Shows Potential in Liver Disease Trial

Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis.

Conexiant

May 01, 2025

Modifiable Risk Factors Linked to Sudden Cardiac Arrest Incidence

A UK Biobank analysis identified 56 modifiable risk factors for sudden cardiac arrest; lifestyle improvements alone could prevent up to 18% of cases, with a total prevention potential of 63%.

Conexiant

April 30, 2025

Is That IPA PFAS-Free?

“Approximately 18% of U.S. breweries are located within zip codes with detectable Per- and polyfluoroalkyl substances (PFAS) in drinking water."

Conexiant